CHIODELLI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 2.053
EU - Europa 1.528
AS - Asia 459
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.049
Nazione #
US - Stati Uniti d'America 2.046
PL - Polonia 930
CN - Cina 256
UA - Ucraina 197
IT - Italia 115
HK - Hong Kong 85
DE - Germania 81
FI - Finlandia 57
GB - Regno Unito 43
IE - Irlanda 42
SG - Singapore 41
VN - Vietnam 40
BE - Belgio 16
FR - Francia 15
IN - India 13
CZ - Repubblica Ceca 9
TR - Turchia 9
SE - Svezia 6
ES - Italia 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CA - Canada 3
IR - Iran 3
JP - Giappone 3
PA - Panama 3
RO - Romania 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
PT - Portogallo 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 4.049
Città #
Warsaw 930
Fairfield 313
Woodbridge 180
Ashburn 176
Jacksonville 149
Houston 142
Chandler 139
Cambridge 131
Ann Arbor 120
Seattle 110
Wilmington 105
Hong Kong 84
Princeton 80
Brescia 60
New York 54
Beijing 49
Nanjing 45
Dong Ket 40
Dublin 40
Helsinki 39
Dearborn 37
Shanghai 23
Singapore 22
San Diego 18
Brussels 16
Des Moines 16
Jinan 16
Hebei 14
Nanchang 12
Jiaxing 11
San Francisco 10
Changsha 9
Leawood 9
Phoenix 9
Hangzhou 8
Kocaeli 8
Shenyang 8
Tianjin 8
Zhengzhou 8
Haikou 7
London 7
Boardman 6
Milan 6
Redwood City 6
Brno 5
Ningbo 5
San Mateo 5
Taizhou 5
Turin 5
Verona 5
Chicago 4
Fuzhou 4
Kunming 4
Lancaster 4
Los Angeles 4
Lozio 4
Munich 4
Augusta 3
Hefei 3
Lappeenranta 3
Orange 3
Rivoli 3
Tokyo 3
Trapani 3
Acton 2
Ardabil 2
Changchun 2
Kilburn 2
Lanzhou 2
Madrid 2
Markham 2
New Bedfont 2
Olomouc 2
Prague 2
Quzhou 2
Rochester 2
Siena 2
Taiyuan 2
Terni 2
Täby 2
Zoetermeer 2
Albacete 1
Amman 1
Amsterdam 1
Baku 1
Bangalore 1
Bergamo 1
Bishkek 1
Canberra 1
Colombo 1
Como 1
Copenhagen 1
Cremona 1
Dubai 1
Ferrara 1
Forest City 1
Greensboro 1
Guangzhou 1
Gunzenhausen 1
Indiana 1
Totale 3.412
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 270
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 238
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 224
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 213
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 211
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 211
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 206
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 173
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 158
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 121
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 118
Sialic acid as a target for the development of novel antiangiogenic strategies 115
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 112
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 109
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 106
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 102
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 98
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 97
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 95
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 94
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 93
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 89
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 87
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 83
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 80
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 68
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 65
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 58
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 53
Long-pentraxin 3 affects primary cilium in zebrafish embryo and cancer cells via the fgf system 51
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 47
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF THE INTERACTION OF GREMLIN (Drm) WITH HEPARIN/HEPARAN SULFATE PROTEOGLYCANS 45
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 33
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines 32
Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis 30
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma 28
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 28
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 27
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 22
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 22
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 13
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 12
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 5
Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells 5
Totale 4.147
Categoria #
all - tutte 17.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.231 110 64 61 111 92 144 141 136 118 125 62 67
2020/2021856 31 78 42 89 72 92 40 88 78 91 101 54
2021/2022385 31 65 11 11 4 20 29 23 27 41 29 94
2022/2023391 52 8 20 16 32 96 5 42 62 2 32 24
2023/2024416 23 9 42 22 13 74 14 24 88 27 24 56
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 4.147